Insider Transactions in Q3 2025 at Ligand Pharmaceuticals Inc (LGND)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2025
|
John W Kozarich Director |
SELL
Open market or private sale
|
Direct |
467
-0.34%
|
$75,654
$162.76 P/Share
|
|
Aug 10
2025
|
Andrew Reardon CLO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,325
-4.12%
|
$198,750
$150.06 P/Share
|
|
Aug 01
2025
|
John W Kozarich Director |
SELL
Open market or private sale
|
Direct |
467
-1.01%
|
$61,177
$131.88 P/Share
|
|
Jul 10
2025
|
John W Kozarich Director |
SELL
Open market or private sale
|
Direct |
934
-1.97%
|
$116,750
$125.0 P/Share
|